case_images: PMC11316962_01
case_images: (a) Breast ultrasound: heterogeneous background echotexture with a hypoechoic area of 7 mm diameter. (b) PET-CT with FDG, performed for the initial cancer staging on April 2022, identified a hypermetabolic pathological tissue of 35 x 58 cm2 on the right side of the cervix, with extension to the vagina and the right parametrium.. FDG, fluorodeoxyglucose; PET-CT, positron emission tomography/computed tomography.
case_images: 10.1177_17588359241259466-fig1.jpg
case_images: PMC11316962_01_10.1177_17588359241259466-fig1.jpg
case_images: fig1-17588359241259466
case_images: Simultaneously, a palpable right-sided breast mass of 3 cm, located in the upper outer quadrant, was discovered through breast ultrasound [Figure 1(a)] and mammography, revealing a heterogeneous background echotexture with a hypoechoic area of 7 mm diameter in the breast without axillary node involvement. A positron emission tomography/computed tomography (PET-CT) with fluorodeoxyglucose found no distant metastases, confirming the presence of pathological cervical neoplastic tissue with high metabolic activity, extending to the vagina [Figure 1(b)].
case_images: Patient medical history timeline.
case_images: 10.1177_17588359241259466-fig2.jpg
case_images: PMC11316962_01_10.1177_17588359241259466-fig2.jpg
case_images: fig2-17588359241259466
case_images: The timeline of cancer history is graphically displayed in Figure 2.